Kairos Pharma, LTD. (KAPA) › Operating Cash FlowKairos Pharma, LTD. (KAPA) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2023: $81.0K2024: -$3.96M2025: -$3.44M-$3.44M2023Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$3.44M+13.0%2024-$3.96M-4982.7%2023$81.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share